Success Metrics

Clinical Success Rate
50.0%

Based on 2 completed trials

Completion Rate
50%(2/4)
Active Trials
1(13%)
Results Posted
0%(0 trials)
Terminated
2(25%)

Phase Distribution

Ph not_applicable
5
63%
Ph phase_2
1
13%

Phase Distribution

0

Early Stage

1

Mid Stage

0

Late Stage

Phase Distribution6 total trials
Phase 2Efficacy & side effects
1(16.7%)
N/ANon-phased studies
5(83.3%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

50.0%

2 of 4 finished

Non-Completion Rate

50.0%

2 ended early

Currently Active

1

trials recruiting

Total Trials

8

all time

Status Distribution
Active(1)
Completed(2)
Terminated(2)
Other(3)

Detailed Status

unknown3
Completed2
Terminated2
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
8
Active
1
Success Rate
50.0%
Most Advanced
Phase 2

Trials by Phase

Phase 21 (16.7%)
N/A5 (83.3%)

Trials by Status

recruiting113%
completed225%
terminated225%
unknown338%

Recent Activity

1 active trials
Showing 5 of 8
recruiting

Is the AMH Intrafollicular Level a Predictor of the Ploidy Status of the Blastocyst?

NCT05837325
completednot_applicable

Direct Thawing of Vitrified Human Blastocyst

NCT06322823
unknown

Methods for Fertility Preservation: Impact of Vitrification on in Vitro Matured Oocytes

NCT03680937
unknownnot_applicable

Vitrification for Ovarian Tissue Harvesting

NCT03649087
terminatednot_applicable

Randomized Controlled Trial Comparing Slow-freezing to Vitrification of Oocytes

NCT00777387
View all 8 trials

Clinical Trials (8)

Showing 8 of 8 trials
NCT05837325

Is the AMH Intrafollicular Level a Predictor of the Ploidy Status of the Blastocyst?

Recruiting
NCT06322823Not Applicable

Direct Thawing of Vitrified Human Blastocyst

Completed
NCT03680937

Methods for Fertility Preservation: Impact of Vitrification on in Vitro Matured Oocytes

Unknown
NCT03649087Not Applicable

Vitrification for Ovarian Tissue Harvesting

Unknown
NCT00777387Not Applicable

Randomized Controlled Trial Comparing Slow-freezing to Vitrification of Oocytes

Terminated
NCT01223105Phase 2

Oocyte Cryopreservation by Slow Freezing and Vitrification

Terminated
NCT00710723Not Applicable

Vitrification Versus Slow Freezing of Human Day 3 Embryos

Unknown
NCT00608010Not Applicable

Day 3 Embryo Cryopreservation: Metabolic and Viability Analysis

Completed

All 8 trials loaded

Drug Details

Intervention Type
OTHER
Total Trials
8